Showing results filtered by:
3 Results
Information about various antimicrobial resistance threats including an overview of other pathogens of concern from NIAID.
Last Reviewed: February 11, 2020
A NIAID-supported Phase 3 clinical trial evaluating an investigational COVID-19 vaccine called AZD1222 will enroll around 30,000 adult volunteers.
Published: August 31, 2020
A fourth Phase 3 NIH clinical trial evaluating an investigational vaccine for coronavirus disease 2019 (COVID-19) has begun enrolling adult volunteers.
Published: September 23, 2020